A detailed history of Waters Parkerson & Co., LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Waters Parkerson & Co., LLC holds 10,539 shares of LLY stock, worth $8.39 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
10,539
Previous 10,505 0.32%
Holding current value
$8.39 Million
Previous $9.51 Million 1.83%
% of portfolio
0.47%
Previous 0.51%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $26,252 - $32,640
34 Added 0.32%
10,539 $9.34 Million
Q2 2024

Aug 12, 2024

SELL
$724.87 - $909.04 $221,810 - $278,166
-306 Reduced 2.83%
10,505 $9.51 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $274,188 - $366,825
463 Added 4.47%
10,811 $8.41 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $237,911 - $280,465
453 Added 4.58%
10,348 $6.03 Million
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $66,509 - $91,692
-153 Reduced 1.52%
9,895 $5.32 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $8,768 - $11,724
-25 Reduced 0.25%
10,048 $4.71 Million
Q4 2022

Feb 09, 2023

SELL
$321.55 - $374.67 $288,430 - $336,078
-897 Reduced 8.18%
10,073 $3.69 Million
Q3 2022

Nov 04, 2022

BUY
$296.48 - $337.87 $85,979 - $97,982
290 Added 2.72%
10,970 $3.55 Million
Q2 2022

Aug 01, 2022

BUY
$278.73 - $327.27 $32,053 - $37,636
115 Added 1.09%
10,680 $3.46 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $33,091 - $41,124
-141 Reduced 1.32%
10,565 $3.03 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $11,692 - $14,510
52 Added 0.49%
10,706 $2.96 Million
Q3 2021

Nov 04, 2021

SELL
$221.6 - $272.71 $96,396 - $118,628
-435 Reduced 3.92%
10,654 $2.46 Million
Q1 2020

May 11, 2020

BUY
$119.05 - $147.35 $14,286 - $17,682
120 Added 1.09%
11,089 $1.54 Million
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $42,768 - $52,972
-400 Reduced 3.52%
10,969 $1.44 Million
Q2 2019

Aug 06, 2019

SELL
$110.79 - $129.32 $110,790 - $129,320
-1,000 Reduced 8.08%
11,369 $1.26 Million
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $369,103 - $434,462
-3,316 Reduced 21.14%
12,369 $1.61 Million
Q4 2018

Feb 12, 2019

SELL
$105.9 - $118.64 $63,540 - $71,184
-600 Reduced 3.68%
15,685 $1.82 Million
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $11,161 - $13,950
130 Added 0.8%
16,285 $1.75 Million
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $50,567 - $58,035
-668 Reduced 3.97%
16,155 $1.38 Million
Q1 2018

May 09, 2018

SELL
$74.21 - $87.6 $1,855 - $2,190
-25 Reduced 0.15%
16,823 $1.3 Million
Q4 2017

Feb 09, 2018

SELL
$81.94 - $87.89 $20,485 - $21,972
-250 Reduced 1.46%
16,848 $1.42 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $240,843 - $267,312
3,125 Added 22.36%
17,098 $1.46 Million
Q2 2017

Aug 11, 2017

BUY
N/A
13,973
13,973 $1.15 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Waters Parkerson & Co., LLC Portfolio

Follow Waters Parkerson & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waters Parkerson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waters Parkerson & Co., LLC with notifications on news.